318 related articles for article (PubMed ID: 25771034)
1. Design, synthesis and biological evaluation of novel sesquiterpene mustards as potential anticancer agents.
Xu YZ; Gu XY; Peng SJ; Fang JG; Zhang YM; Huang DJ; Chen JJ; Gao K
Eur J Med Chem; 2015 Apr; 94():284-97. PubMed ID: 25771034
[TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of novel quinazoline nitrogen mustard derivatives as potential therapeutic agents for cancer.
Li S; Wang X; He Y; Zhao M; Chen Y; Xu J; Feng M; Chang J; Ning H; Qi C
Eur J Med Chem; 2013 Sep; 67():293-301. PubMed ID: 23871909
[TBL] [Abstract][Full Text] [Related]
3. A rational design strategy of the novel topoisomerase II inhibitors for the synthesis of the 4-O-(2-pyrazinecarboxylic)-4'-demethylepipodophyllotoxin with antitumor activity by diminishing the relaxation reaction of topoisomerase II-DNA decatenation.
Zhao W; Chen L; Li HM; Wang DJ; Li DS; Chen T; Yuan ZP; Tang YJ
Bioorg Med Chem; 2014 Jun; 22(11):2998-3007. PubMed ID: 24775914
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of novel 1,2,3-triazole-pyrimidine hybrids as potential anticancer agents.
Ma LY; Pang LP; Wang B; Zhang M; Hu B; Xue DQ; Shao KP; Zhang BL; Liu Y; Zhang E; Liu HM
Eur J Med Chem; 2014 Oct; 86():368-80. PubMed ID: 25180925
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and in vitro antitumor activity of novel N-substituted-4-phenyl/benzylphthalazin-1-ones.
Eldehna WM; Ibrahim HS; Abdel-Aziz HA; Farrag NN; Youssef MM
Eur J Med Chem; 2015 Jan; 89():549-60. PubMed ID: 25462265
[TBL] [Abstract][Full Text] [Related]
6. Novel enmein-type diterpenoid hybrids coupled with nitrogen mustards: Synthesis of promising candidates for anticancer therapeutics.
Gao X; Li J; Wang M; Xu S; Liu W; Zang L; Li Z; Hua H; Xu J; Li D
Eur J Med Chem; 2018 Feb; 146():588-598. PubMed ID: 29407983
[TBL] [Abstract][Full Text] [Related]
7. Novel hybrids of brefeldin A and nitrogen mustards with improved antiproliferative selectivity: Design, synthesis and antitumor biological evaluation.
Han T; Tian K; Pan H; Liu Y; Xu F; Li Z; Uchita T; Gao M; Hua H; Li D
Eur J Med Chem; 2018 Apr; 150():53-63. PubMed ID: 29524728
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and antiproliferative activity studies of novel 1,2,3-triazole-dithiocarbamate-urea hybrids.
Duan YC; Zheng YC; Li XC; Wang MM; Ye XW; Guan YY; Liu GZ; Zheng JX; Liu HM
Eur J Med Chem; 2013 Jun; 64():99-110. PubMed ID: 23644193
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of novel pyrazolo[1,5-a]pyrimidine derivatives bearing nitrogen mustard moiety and evaluation of their antitumor activity in vitro and in vivo.
Zhao M; Ren H; Chang J; Zhang D; Yang Y; He Y; Qi C; Zhang H
Eur J Med Chem; 2016 Aug; 119():183-96. PubMed ID: 27162123
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antitumor activity of formononetin nitrogen mustard derivatives.
Ren J; Xu HJ; Cheng H; Xin WQ; Chen X; Hu K
Eur J Med Chem; 2012 Aug; 54():175-87. PubMed ID: 22633834
[TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of novel 1,2,3-triazole derivatives of coronopilin as anti-cancer compounds.
Khazir J; Hyder I; Gayatri JL; Prasad Yandrati L; Nalla N; Chasoo G; Mahajan A; Saxena AK; Alam MS; Qazi GN; Sampath Kumar HM
Eur J Med Chem; 2014 Jul; 82():255-62. PubMed ID: 24910974
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological studies of the thiols-triggered anticancer prodrug for a more effective cancer therapy.
Xu Y; Chen J; Li Y; Peng S; Gu X; Sun M; Gao K; Fang J
Org Biomol Chem; 2015 Mar; 13(9):2634-9. PubMed ID: 25581090
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and biological evaluation of novel pyrenyl derivatives as anticancer agents.
Bandyopadhyay D; Sanchez JL; Guerrero AM; Chang FM; Granados JC; Short JD; Banik BK
Eur J Med Chem; 2015 Jan; 89():851-62. PubMed ID: 25462285
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of novel 1,2,3-triazole-dithiocarbamate hybrids as potential anticancer agents.
Duan YC; Ma YC; Zhang E; Shi XJ; Wang MM; Ye XW; Liu HM
Eur J Med Chem; 2013 Apr; 62():11-9. PubMed ID: 23353743
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and biological evaluations of chirally pure 1,2,3,4-tertrahydroisoquinoline analogs as anti-cancer agents.
Ramanivas T; Sushma B; Nayak VL; Chandra Shekar K; Srivastava AK
Eur J Med Chem; 2015 Mar; 92():608-18. PubMed ID: 25615796
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and in vitro evaluation of novel ursolic acid derivatives as potential anticancer agents.
Hua SX; Huang RZ; Ye MY; Pan YM; Yao GY; Zhang Y; Wang HS
Eur J Med Chem; 2015 May; 95():435-52. PubMed ID: 25841199
[TBL] [Abstract][Full Text] [Related]
17. Spirooxindole-derived morpholine-fused-1,2,3-triazoles: Design, synthesis, cytotoxicity and apoptosis inducing studies.
Senwar KR; Sharma P; Reddy TS; Jeengar MK; Nayak VL; Naidu VG; Kamal A; Shankaraiah N
Eur J Med Chem; 2015 Sep; 102():413-24. PubMed ID: 26301558
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antitumor activities of novel thiourea α-aminophosphonates from dehydroabietic acid.
Huang XC; Wang M; Pan YM; Yao GY; Wang HS; Tian XY; Qin JK; Zhang Y
Eur J Med Chem; 2013 Nov; 69():508-20. PubMed ID: 24095745
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, anticancer activity and effects on cell cycle profile and apoptosis of novel thieno[2,3-d]pyrimidine and thieno[3,2-e] triazolo[4,3-c]pyrimidine derivatives.
Kandeel MM; Refaat HM; Kassab AE; Shahin IG; Abdelghany TM
Eur J Med Chem; 2015 Jan; 90():620-32. PubMed ID: 25499930
[TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of novel nitrogen mustard-evodiamine hybrids with selective antiproliferative activity.
Hu X; Wang Y; Xue J; Han T; Jiao R; Li Z; Liu W; Xu F; Hua H; Li D
Bioorg Med Chem Lett; 2017 Nov; 27(22):4989-4993. PubMed ID: 29037951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
